Fig. 5: Analysis of ARGs, MRGs, and BRGs across different samples.

a–c ARGs. a Relative abundance. b ANOVA analysis. b1, b2 Significant gene contribution analysis. b1 Zoliflodacin-like antibiotic, b2 Fusidane antibiotic. c PCoA analysis. d–f MRGs and BRGs. d Relative abundance. e ANOVA analysis. e1, e2 Significant gene contribution analysis. e1 Zinc (Zn), e2: Silver (Ag). f PCoA analysis.